W. Classen

发表

Ventricular size, cognitive and psychomotor performance, and laterality in schizophrenia

J. Fritze, W. Classen, 1989, Psychiatry Research.

Schizophrenia-like psychosis associated with an arachnoid cyst visualized by mapping of EEG and P300

R. Ihl, K. Maurer, J. Fritze, 1989, Psychiatry Research.

Use of Placebos in Medical Practice

W. Classen, E. Feingold, 1985 .

Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.

G. Laux, W. Classen, 1990, Journal of neural transmission. Supplementum.

Psychomotor investigations in depressed patients by comparison with Parkinson patients

G. Laux, W. Kuhn, W. Classen, 1989 .

Sensorimotor and Cognitive Performance of Schizophrenic Inpatients Treated with Haloperidol, Flupenthixol, or Clozapine

G. Laux, W. Classen, 1988, Pharmacopsychiatry.

Impaired temporal discrimination in Parkinson's disease: temporal processing of brief durations as an indicator of degeneration of dopaminergic neurons in the basal ganglia.

T. Rammsayer, T Rammsayer, W Classen, 1997, The International journal of neuroscience.

Placebo Application, Personality, and Headaches: A Signal Detection Theory Analysis of Experimentally Induced Pain in Comparison to Clinical Pain

W. Classen, 1984, Pharmacopsychiatry.

Influence of sensory suggestibility on treatment outcome in headache patients.

P. Netter, W. Classen, E. Feingold, 1983, Neuropsychobiology.

Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.

K. Lesch, P. Riederer, G. Laux, 1990, Journal of neural transmission. Supplementum.

Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.

G. Laux, W. Classen, 1989, Neuropsychobiology.